Century Therapeutics, Inc. License Agreements
11 Contracts & Agreements
- License Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 22, 2023 (Filed With SEC on March 14, 2024)
- Second Amendment to License Agreement (Differentiation), by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Filed With SEC on November 9, 2023)
- Second Amendment to License Agreement (Reprogramming), by and between the Company and FUJIFILM Cellular Dynamics Inc., dated September 22, 2023 (Filed With SEC on November 9, 2023)
- License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
- License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
- License Agreement, by and between Inscripta, Inc. and Century Therapeutics, Inc., dated January 1, 2019 (Filed With SEC on May 28, 2021)
- License Agreement, by and among the Governing Council of the University of Toronto, the McMaster University and Empirica Therapeutics, dated January 22, 2019 (Filed With SEC on May 28, 2021)
- Amendment No. 1 to License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021 (Filed With SEC on May 28, 2021)
- License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
- Amendment No. 1 to License Agreement (Differentiation), by and between Century Therapeutics, Inc (Filed With SEC on May 28, 2021)
- License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
